SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-114679
Filing Date
2021-04-13
Accepted
2021-04-13 16:07:04
Documents
14
Period of Report
2021-04-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d149094d8k.htm   iXBRL 8-K 27735
2 EX-99.1 d149094dex991.htm EX-99.1 5105
6 GRAPHIC g149094g0413140544753.jpg GRAPHIC 2692
  Complete submission text file 0001193125-21-114679.txt   160781

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20210413.xsd EX-101.SCH 2727
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20210413_lab.xml EX-101.LAB 18081
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20210413_pre.xml EX-101.PRE 11367
7 EXTRACTED XBRL INSTANCE DOCUMENT d149094d8k_htm.xml XML 3450
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 21823157
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences